MetLife Inc (MET) - Net Assets
Based on the latest financial reports, MetLife Inc (MET) has net assets worth $25.43 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($741.67 Billion) and total liabilities ($716.25 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MET financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $25.43 Billion |
| % of Total Assets | 3.43% |
| Annual Growth Rate | 2.5% |
| 5-Year Change | -57.31% |
| 10-Year Change | -57.28% |
| Growth Volatility | 20.75 |
MetLife Inc - Net Assets Trend (1998–2025)
This chart illustrates how MetLife Inc's net assets have evolved over time, based on quarterly financial data. Also explore MetLife Inc assets under control for the complete picture of this company's asset base.
Annual Net Assets for MetLife Inc (1998–2025)
The table below shows the annual net assets of MetLife Inc from 1998 to 2025. For live valuation and market cap data, see MET stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $28.92 Billion | +4.40% |
| 2024-12-31 | $27.70 Billion | -8.43% |
| 2023-12-31 | $30.25 Billion | +0.42% |
| 2022-12-31 | $30.12 Billion | -55.53% |
| 2021-12-31 | $67.75 Billion | -9.45% |
| 2020-12-31 | $74.82 Billion | +12.71% |
| 2019-12-31 | $66.38 Billion | +25.35% |
| 2018-12-31 | $52.96 Billion | -10.04% |
| 2017-12-31 | $58.87 Billion | -13.05% |
| 2016-12-31 | $67.70 Billion | -1.16% |
| 2015-12-31 | $68.50 Billion | -5.73% |
| 2014-12-31 | $72.66 Billion | +15.36% |
| 2013-12-31 | $62.98 Billion | -3.04% |
| 2012-12-31 | $64.96 Billion | +26.88% |
| 2011-12-31 | $51.20 Billion | +4.24% |
| 2010-12-31 | $49.11 Billion | +46.61% |
| 2009-12-31 | $33.50 Billion | +39.66% |
| 2008-12-31 | $23.98 Billion | -31.82% |
| 2007-12-31 | $35.18 Billion | +4.09% |
| 2006-12-31 | $33.80 Billion | +16.14% |
| 2005-12-31 | $29.10 Billion | +27.50% |
| 2004-12-31 | $22.82 Billion | +7.92% |
| 2003-12-31 | $21.15 Billion | +13.40% |
| 2002-12-31 | $18.65 Billion | +7.69% |
| 2001-12-31 | $17.32 Billion | -0.92% |
| 2000-12-31 | $17.48 Billion | +27.68% |
| 1999-12-31 | $13.69 Billion | -7.92% |
| 1998-12-31 | $14.87 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to MetLife Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 228.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $44.29 Billion | 155.96% |
| Common Stock | $12.00 Million | 0.04% |
| Other Comprehensive Income | $-18.08 Billion | -63.68% |
| Other Components | $2.18 Billion | 7.68% |
| Total Equity | $28.40 Billion | 100.00% |
MetLife Inc Competitors by Market Cap
The table below lists competitors of MetLife Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SOFTBANK CORP. ADR
F:3AG0
|
$52.06 Billion |
|
DSV ADR 2 DK 1
F:DS8
|
$52.08 Billion |
|
E.ON SE
F:EOAN
|
$52.11 Billion |
|
Infosys Ltd ADR
NYSE:INFY
|
$52.35 Billion |
|
Infosys Limited
NSE:INFY
|
$51.72 Billion |
|
Sandvik AB
ST:SAND
|
$51.72 Billion |
|
Fastenal Company
NASDAQ:FAST
|
$51.57 Billion |
|
Cameco Corp
TO:CCO
|
$51.55 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MetLife Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 27,445,000,000 to 28,398,000,000, a change of 953,000,000 (3.5%).
- Net income of 3,379,000,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 3,102,000,000.
- Other factors decreased equity by 5,528,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $3.38 Billion | +11.9% |
| Other Comprehensive Income | $3.10 Billion | +10.92% |
| Other Changes | $-5.53 Billion | -19.47% |
| Total Change | $- | 3.47% |
Book Value vs Market Value Analysis
This analysis compares MetLife Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.88x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.22x to 1.88x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $19.00 | $80.23 | x |
| 1999-12-31 | $17.50 | $80.23 | x |
| 2000-12-31 | $25.62 | $80.23 | x |
| 2001-12-31 | $21.05 | $80.23 | x |
| 2002-12-31 | $23.83 | $80.23 | x |
| 2003-12-31 | $28.31 | $80.23 | x |
| 2004-12-31 | $30.23 | $80.23 | x |
| 2005-12-31 | $38.54 | $80.23 | x |
| 2006-12-31 | $43.85 | $80.23 | x |
| 2007-12-31 | $46.15 | $80.23 | x |
| 2008-12-31 | $31.87 | $80.23 | x |
| 2009-12-31 | $40.47 | $80.23 | x |
| 2010-12-31 | $49.32 | $80.23 | x |
| 2011-12-31 | $54.37 | $80.23 | x |
| 2012-12-31 | $59.04 | $80.23 | x |
| 2013-12-31 | $54.86 | $80.23 | x |
| 2014-12-31 | $63.66 | $80.23 | x |
| 2015-12-31 | $60.22 | $80.23 | x |
| 2016-12-31 | $61.64 | $80.23 | x |
| 2017-12-31 | $56.23 | $80.23 | x |
| 2018-12-31 | $52.02 | $80.23 | x |
| 2019-12-31 | $70.04 | $80.23 | x |
| 2020-12-31 | $81.64 | $80.23 | x |
| 2021-12-31 | $77.62 | $80.23 | x |
| 2022-12-31 | $36.94 | $80.23 | x |
| 2023-12-31 | $39.37 | $80.23 | x |
| 2024-12-31 | $38.60 | $80.23 | x |
| 2025-12-31 | $42.71 | $80.23 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MetLife Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.90%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.38%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 26.24x
- Recent ROE (11.90%) is above the historical average (8.71%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 9.03% | 5.06% | 0.12x | 14.48x | $-143.70 Million |
| 1999 | 4.51% | 2.49% | 0.11x | 16.45x | $-752.00 Million |
| 2000 | 5.81% | 3.11% | 0.12x | 15.51x | $-685.90 Million |
| 2001 | 2.94% | 1.55% | 0.12x | 16.00x | $-1.13 Billion |
| 2002 | 9.23% | 4.94% | 0.12x | 15.96x | $-133.50 Million |
| 2003 | 10.48% | 6.32% | 0.11x | 15.45x | $102.10 Million |
| 2004 | 12.08% | 7.13% | 0.11x | 15.63x | $475.60 Million |
| 2005 | 16.20% | 10.56% | 0.09x | 16.55x | $1.80 Billion |
| 2006 | 18.62% | 13.04% | 0.09x | 15.61x | $2.91 Billion |
| 2007 | 12.27% | 8.14% | 0.09x | 15.89x | $799.10 Million |
| 2008 | 13.52% | 6.29% | 0.10x | 21.14x | $835.60 Million |
| 2009 | -6.78% | -5.47% | 0.08x | 16.28x | $-5.56 Billion |
| 2010 | 5.48% | 5.10% | 0.07x | 15.03x | $-2.20 Billion |
| 2011 | 11.17% | 9.14% | 0.09x | 13.90x | $671.10 Million |
| 2012 | 2.05% | 2.00% | 0.08x | 12.98x | $-5.12 Billion |
| 2013 | 5.47% | 4.94% | 0.08x | 14.38x | $-2.79 Billion |
| 2014 | 8.76% | 8.61% | 0.08x | 12.52x | $-896.30 Million |
| 2015 | 7.91% | 8.76% | 0.07x | 12.92x | $-1.42 Billion |
| 2016 | 1.26% | 1.40% | 0.07x | 13.31x | $-5.90 Billion |
| 2017 | 6.83% | 6.44% | 0.09x | 12.27x | $-1.86 Billion |
| 2018 | 9.71% | 7.54% | 0.10x | 13.04x | $-151.10 Million |
| 2019 | 8.92% | 8.47% | 0.09x | 11.19x | $-715.40 Million |
| 2020 | 7.25% | 7.96% | 0.09x | 10.66x | $-2.05 Billion |
| 2021 | 10.16% | 10.82% | 0.08x | 11.26x | $106.80 Million |
| 2022 | 17.68% | 7.77% | 0.10x | 22.19x | $2.30 Billion |
| 2023 | 5.26% | 2.33% | 0.10x | 22.91x | $-1.42 Billion |
| 2024 | 16.13% | 6.24% | 0.10x | 24.68x | $1.68 Billion |
| 2025 | 11.90% | 4.38% | 0.10x | 26.24x | $539.20 Million |
Industry Comparison
This section compares MetLife Inc's net assets metrics with peer companies in the Insurance - Life industry.
Industry Context
- Industry: Insurance - Life
- Average net assets among peers: $13,304,963,934
- Average return on equity (ROE) among peers: 8.69%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MetLife Inc (MET) | $25.43 Billion | 9.03% | 28.17x | $51.78 Billion |
| Atlantic American Corporation (AAME) | $31.80 Million | 29.56% | 5.46x | $48.34 Million |
| Abacus Life Inc. (ABL) | $423.29 Million | -5.66% | 1.07x | $827.97 Million |
| Abacus Global Management, Inc. (ABX) | $423.29 Million | -5.66% | 1.07x | $87.97K |
| Aflac Incorporated (AFL) | $6.65 Billion | 11.96% | 6.67x | $58.55 Billion |
| Brighthouse Financial Inc (BHF) | $14.48 Billion | 5.97% | 13.24x | $3.58 Billion |
| Citizens Inc (CIA) | $176.16 Million | 9.40% | 3.47x | $269.61 Million |
| CNO Financial Group Inc (CNO) | $3.37 Billion | -9.34% | 8.33x | $4.11 Billion |
| F&G Annuities & Life Inc. (FG) | $1.82 Billion | 34.97% | 29.33x | $3.39 Billion |
| Globe Life Inc (GL) | $3.46 Billion | 14.99% | 3.33x | $11.46 Billion |
| Genworth Financial Inc (GNW) | $102.22 Billion | 0.74% | 0.03x | $3.52 Billion |
About MetLife Inc
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, indi… Read more